Atlas Trials

Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

Clinical trial NCT05490836 · UNKNOWN

Trial details

NCT number
NCT05490836
Sponsor
Huashan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2022-09-01
Primary completion
2024-08-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.